These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27423391)
1. Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis. Fujita K; Terashima T; Mio T J Thorac Oncol; 2016 Dec; 11(12):2238-2240. PubMed ID: 27423391 [TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy. La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482 [TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer. Tanvetyanon T; Creelan BC; Antonia SJ Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges. Giroux Leprieur E; Dumenil C; Julie C; Giraud V; Dumoulin J; Labrune S; Chinet T Eur J Cancer; 2017 Jun; 78():16-23. PubMed ID: 28407528 [TBL] [Abstract][Full Text] [Related]
5. [Anti-PD1 immunotherapy followed by tuberculosis infection or reactivation]. Viatgé T; Mazières J; Zahi S; Fajadet P; Pétureau F Rev Mal Respir; 2020 Sep; 37(7):595-601. PubMed ID: 32636051 [TBL] [Abstract][Full Text] [Related]
6. The safety of nivolumab for the treatment of advanced non-small cell lung cancer. Metro G; Ricciuti B; Brambilla M; Baglivo S; Soli I; Minenza E; Leonardi GC; D'arpino A; Colabrese D; Tazza M; Zicari D; Minotti V; Chiari R Expert Opin Drug Saf; 2017 Jan; 16(1):101-109. PubMed ID: 27910704 [TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors as first-line and salvage therapy for advanced non-small-cell lung cancer. Decatris MP; O'Byrne KJ Future Oncol; 2016 Aug; 12(15):1805-22. PubMed ID: 27267211 [TBL] [Abstract][Full Text] [Related]
8. [Development of immune checkpoint inhibitors]. Kitano S Rinsho Ketsueki; 2017; 58(8):966-976. PubMed ID: 28883282 [TBL] [Abstract][Full Text] [Related]